AMAT
43
-5
PCG
85
2
EXPD
48
3
ED
39
2
REGN
53
-3
CRM
59
2
MMC
62
2
BAC
54
3
TSCO
60
2
IRM
75
2
R
66
3
KMI
63
4
CMS
57
2
DE
49
9
EXC
56
2
MA
69
5
DUK
55
6
DIS
56
7
F
47
3
AMP
72
2
AMAT
43
-5
PCG
85
2
EXPD
48
3
ED
39
2
REGN
53
-3
CRM
59
2
MMC
62
2
BAC
54
3
TSCO
60
2
IRM
75
2
R
66
3
KMI
63
4
CMS
57
2
DE
49
9
EXC
56
2
MA
69
5
DUK
55
6
DIS
56
7
F
47
3
AMP
72
2
Financhill
Back

ProShares UltraShort Energy Vs. Kymera Therapeutics Industry Stock Comparison

Sell
35

DUG
ProShares UltraShort Energy

Last Price:
9.41
Seasonality Move:
-11.31%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.94
Seasonality Move:
65.72%
Sell
35
ProShares UltraShort Energy (DUG) is a Sell

Is ProShares UltraShort Energy a Buy, Sell or Hold?

  • The current ProShares UltraShort Energy [DUG] share price is $9.48. The Score for DUG is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • DUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DUG Stock Price Chart

What is ProShares UltraShort Energy's stock price today?

  • The ProShares UltraShort Energy share price today is $9.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUG is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 47.18 Sell
Chaikin Money Flow: -6458 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.16 - 10.44) Sell
Bollinger Bands (100): (9.39 - 10.37) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

DUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.19 Buy
20-day SMA: 9.58 Sell
50-day SMA: 9.94 Sell
200-day SMA: 10.11 Sell
8-day EMA: 9.31 Buy
20-day EMA: 9.54 Sell
50-day EMA: 9.78 Sell
200-day EMA: 10.28 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares UltraShort Energy Earnings Growth & DUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares UltraShort Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):